Crossref
FDA Approves Menopausal Hormone Therapy Labeling Changes
JAMA · 24.03.2026 · 335 (12) · 1024
DOI: 10.1001/jama.2025.26404 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA, erschienen am 24.03.2026. Verfasst von Samantha Anderer.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Anderer, S. (2026). FDA Approves Menopausal Hormone Therapy Labeling Changes. JAMA, 335(12), 1024. https://doi.org/10.1001/jama.2025.26404
Vancouver
Anderer S. FDA Approves Menopausal Hormone Therapy Labeling Changes. JAMA. 2026;335(12):1024. doi:10.1001/jama.2025.26404
BibTeX
@article{Anderer2026,
author = {Anderer, Samantha},
title = {FDA Approves Menopausal Hormone Therapy Labeling Changes},
journal = {JAMA},
year = {2026},
volume = {335},
number = {12},
pages = {1024},
doi = {10.1001/jama.2025.26404}
}
EUVIMED